BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Clinical Outcome
22 results:

  • 1. [clinical analysis of lung adenocarcinoma with epidermal growth factor receptor mutation transformed into sarcoma].
    Zhu QQ; Du MZ; Wu WT; Guo LC; Huang JA; Shen D
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):24-30. PubMed ID: 38062690
    [No Abstract]    [Full Text] [Related]  

  • 2. Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. clinical outcome and actionable molecular alterations.
    Conforti F; Pala L; Pagan E; Rocco EG; Bagnardi V; Montagna E; Peruzzotti G; De Pas T; Fumagalli C; Pileggi S; Pesenti C; Marchini S; Corso G; Marchio' C; Sapino A; Graffeo R; Collet L; Aftimos P; Sotiriou C; Piccart M; Gelber RD; Viale G; Colleoni M; Goldhirsch A
    Breast; 2021 Oct; 59():94-101. PubMed ID: 34217971
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: clinical and Patient-Reported outcomes 1 Year After Surgery.
    Fiore M; Brunelli C; Miceli R; Manara M; Lenna S; Rampello NN; Callegaro D; Colombo C; Radaelli S; Pasquali S; Caraceni AT; Gronchi A
    Ann Surg Oncol; 2021 Jul; 28(7):3904-3916. PubMed ID: 33175262
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer.
    Reissig TM; Sara L; Ting S; Reis H; Metzenmacher M; Eberhardt WEE; Zaun G; Herold T; Aigner C; Darwiche K; Stuschke M; Schildhaus HU; Schuler M; Wiesweg M
    Lung Cancer; 2020 Nov; 149():10-16. PubMed ID: 32947221
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. egfr expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas.
    Braun AC; de Mello CAL; Corassa M; Abdallah EA; Urvanegia AC; Alves VS; Flores BCTCP; Díaz M; Nicolau UR; Silva VSE; Calsavara V; Paterlini-Brechót P; Chinen LTD
    Cancer Biol Ther; 2018 Jun; 19(6):454-460. PubMed ID: 29394136
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chemotherapy plus targeted drugs in conversion therapy for potentially resectable colorectal liver metastases: a meta-analysis.
    Wang L; Sun Y; Zhao B; Zhang H; Yu Q; Yuan X
    Oncotarget; 2016 Aug; 7(34):55732-55740. PubMed ID: 27248177
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma.
    Yang CY; Lin MW; Chang YL; Wu CT; Yang PC
    Eur J Cancer; 2016 Apr; 57():91-103. PubMed ID: 26901614
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
    Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
    Song QB; Wang Q; Hu WG
    World J Gastroenterol; 2015 Apr; 21(14):4365-72. PubMed ID: 25892888
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Breast phyllodes tumor: a review of literature and a single center retrospective series analysis.
    Spitaleri G; Toesca A; Botteri E; Bottiglieri L; Rotmensz N; Boselli S; Sangalli C; Catania C; Toffalorio F; Noberasco C; Delmonte A; Luini A; Veronesi P; Colleoni M; Viale G; Zurrida S; Goldhirsch A; Veronesi U; De Pas T
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):427-36. PubMed ID: 23871531
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer.
    Woo J; Palmisiano N; Tester W; Leighton JC
    Cancer; 2013 Jun; 119(11):1941-50. PubMed ID: 23504768
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.
    Ragusa M; Vannucci J; Ludovini V; Bianconi F; Treggiari S; Tofanetti FR; Flacco A; Colella R; Sidoni A; Crinò L; Puma F
    Am J Clin Oncol; 2014 Aug; 37(4):343-9. PubMed ID: 23357969
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
    Friedland P; Thomas A; Naran A; Amanuel B; Grieu-Iacopetta F; Carrello A; Harnett G; Meyer C; Phillips M
    ANZ J Surg; 2012 May; 82(5):362-6. PubMed ID: 22507644
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.
    De Pas T; Toffalorio F; Manzotti M; Fumagalli C; Spitaleri G; Catania C; Delmonte A; Giovannini M; Spaggiari L; de Braud F; Barberis M
    J Thorac Oncol; 2011 Nov; 6(11):1895-901. PubMed ID: 21841502
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome.
    García-Foncillas J; Díaz-Rubio E
    Clin Transl Oncol; 2010 Aug; 12(8):533-42. PubMed ID: 20709651
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Biological importance of a polymorphic CA sequence within intron 1 of the epidermal growth factor receptor gene (egfr) in high grade central osteosarcomas.
    Kersting C; Agelopoulos K; Schmidt H; Korsching E; August C; Gosheger G; Dirksen U; Juergens H; Winkelmann W; Brandt B; Bielack S; Buerger H; Gebert C
    Genes Chromosomes Cancer; 2008 Aug; 47(8):657-64. PubMed ID: 18464244
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Epidermal growth factor receptor expression in high-grade osteosarcomas is associated with a good clinical outcome.
    Kersting C; Gebert C; Agelopoulos K; Schmidt H; van Diest PJ; Juergens H; Winkelmann W; Kevric M; Gosheger G; Brandt B; Bielack S; Buerger H
    Clin Cancer Res; 2007 May; 13(10):2998-3005. PubMed ID: 17505002
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
    Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
    Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast.
    Yonemori K; Hasegawa T; Shimizu C; Shibata T; Matsumoto K; Kouno T; Ando M; Katsumata N; Fujiwara Y
    Pathol Res Pract; 2006; 202(10):705-12. PubMed ID: 16889904
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pitfalls in immunohistochemical assessment of egfr expression in soft tissue sarcomas.
    Kersting C; Packeisen J; Leidinger B; Brandt B; von Wasielewski R; Winkelmann W; van Diest PJ; Gosheger G; Buerger H
    J Clin Pathol; 2006 Jun; 59(6):585-90. PubMed ID: 16461571
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.